• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Coherus Biosciences, Inc. (CHRS)

    -NasdaqGM
    12.76 Down 0.39(2.97%) Dec 19, 4:00PM EST
    |After Hours : 12.76 Down 0.00 (0.03%) Dec 19, 5:35PM EST
    Add to Portfolio
    Prev Close:13.15
    Open:13.07
    Bid:N/A
    Ask:24.00 x 100
    1y Target Est:7.35
    Beta:1.71
    Next Earnings Date:N/A
    Day's Range:12.70 - 13.43
    52wk Range:12.38 - 15.53
    Volume:927,084
    Avg Vol (3m):174,976
    Market Cap:408.97M
    P/E (ttm):N/A
    EPS (ttm):-2.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):40.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jan-13) :N/A
    Quarterly EPS Est (Jul-12) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback